Clinical Trials Insight: 700034077
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 30 May 2008
At a glance
- Drugs Bevacizumab; Carboplatin; Dulanermin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 30 May 2008 New trial record.
- 16 May 2008 Interim results will be presented at ASCO in May.